|1.||Gambari, Roberto: 6 articles (01/2015 - 01/2004)|
|2.||Corradini, Roberto: 5 articles (01/2015 - 01/2004)|
|3.||Borgatti, Monica: 5 articles (01/2015 - 01/2005)|
|4.||Fabbri, Enrica: 4 articles (01/2015 - 01/2005)|
|5.||Bianchi, Nicoletta: 4 articles (01/2015 - 01/2005)|
|6.||Manicardi, Alex: 4 articles (01/2015 - 12/2012)|
|7.||Breveglieri, Giulia: 3 articles (01/2015 - 12/2012)|
|8.||Lampronti, Ilaria: 3 articles (01/2015 - 01/2005)|
|9.||Finotti, Alessia: 3 articles (01/2015 - 12/2012)|
|10.||Montagner, Giulia: 2 articles (01/2015 - 05/2014)|
06/08/2004 - "HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs)."
02/15/2013 - "Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models."
02/01/2008 - "CPPs could also more efficiently internalize radiolabeled antisense ODNs or peptide nucleic acids (PNAs) into tumor cells to enhance the sensitivity of imaging gene expression at the mRNA level. "
03/01/2005 - "MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids."
01/01/2005 - "We have recently shown that an MCF-7 tumor can be imaged in a mouse by PET with 64Cu-labeled Peptide nucleic acids (PNAs) tethered to the permeation peptide Lys4 that recognize the uniquely overexpressed and very abundant upstream of N-ras or N-ras related gene (unr mRNA) expressed in these cells. "
|2.||Pancreatic Neoplasms (Pancreatic Cancer)
01/31/2005 - "In the present study, we combined the PCR-clamping approach with melting curve analysis using mutant specific hybridisation probes and wild-type specific peptide nucleic acids (PNAs) to determine the genotypes of the most frequent point mutation in codon 12 of the proto-oncogene Ki-ras in tissue and plasma samples of patients with pancreatic cancer. "
|3.||Neoplasm Metastasis (Metastasis)
|4.||Type 2 Diabetes Mellitus (MODY)
|5.||Cystic Fibrosis (Mucoviscidosis)
10/01/2001 - "In this paper we demonstrate that peptide nucleic acids (PNAs) are excellent probes able to detect the W1282X point mutation of the cystic fibrosis (CF) gene when biospecific interaction analysis (BIA) by surface plasmon resonance (SPR) and biosensor technologies is performed. "
10/01/2001 - "Peptide nucleic acids and biosensor technology for real-time detection of the cystic fibrosis W1282X mutation by surface plasmon resonance."
01/01/2014 - "In this paper, peptide nucleic acids (PNAs) containing 1 to 3 1-pyreneacetic acid units (PNA1-6) with a sequence with prevalence of pyrimidine bases, complementary to cystic fibrosis W1282X point mutation were synthesized. "
01/01/2004 - "Peptide nucleic acids (PNAs) containing an insert of three chiral monomers based on D-lysine ('chiral box') were synthesized and used as probes in Biospecific Interaction Analysis (BIA) for the recognition of DNA containing the W1282X point mutation of the cystic fibrosis gene. "
12/15/2010 - "Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa."
|1.||DNA (Deoxyribonucleic Acid)
|2.||Telomerase (Telomerase Reverse Transcriptase)
|3.||Catalytic RNA (Ribozymes)
|4.||Indicators and Reagents (Reagents)
|6.||Messenger RNA (mRNA)
|7.||Virulence Factors (Pathogenicity Factors)
|9.||beta-Globins (beta Globin)
|10.||Guanidine (Guanidine Nitrate)